These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 18467037)

  • 1. Clear cell adenocarcinoma arising from a giant cystic adenomyosis: a case report with immunohistochemical analysis of laminin-5 gamma2 chain and p53 overexpression.
    Ohta Y; Hamatani S; Suzuki T; Ikeda K; Kiyokawa K; Shiokawa A; Kushima M; Ota H
    Pathol Res Pract; 2008; 204(9):677-82. PubMed ID: 18467037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative immunohistochemical studies of bcl-2 and p53 proteins in benign and malignant ovarian endometriotic cysts.
    Nezhat F; Cohen C; Rahaman J; Gretz H; Cole P; Kalir T
    Cancer; 2002 Jun; 94(11):2935-40. PubMed ID: 12115382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of CD10 staining in distinguishing invasive endometrial adenocarcinoma from adenocarcinoma involving adenomyosis.
    Nascimento AF; Hirsch MS; Cviko A; Quade BJ; Nucci MR
    Mod Pathol; 2003 Jan; 16(1):22-7. PubMed ID: 12527709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. P53 expression in adenomyosis in endometrial carcinoma patients.
    Taskin M; Lallas TA; Shevchuk M; Barber HR
    Gynecol Oncol; 1996 Aug; 62(2):241-6. PubMed ID: 8751556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clear cell adenocarcinoma arising from adenomyosis.
    Hirabayashi K; Yasuda M; Kajiwara H; Nakamura N; Sato S; Nishijima Y; Mikami M; Osamura RY
    Int J Gynecol Pathol; 2009 May; 28(3):262-6. PubMed ID: 19620944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenomyosis involved by endometrial adenocarcinoma is a significant risk factor for deep myometrial invasion.
    Ismiil N; Rasty G; Ghorab Z; Nofech-Mozes S; Bernardini M; Ackerman I; Thomas G; Covens A; Khalifa MA
    Ann Diagn Pathol; 2007 Aug; 11(4):252-7. PubMed ID: 17630108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenomyosis is associated with myometrial invasion by FIGO 1 endometrial adenocarcinoma.
    Ismiil ND; Rasty G; Ghorab Z; Nofech-Mozes S; Bernardini M; Thomas G; Ackerman I; Covens A; Khalifa MA
    Int J Gynecol Pathol; 2007 Jul; 26(3):278-83. PubMed ID: 17581412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of laminin gamma2 chain monomer in invading gastric carcinoma cells.
    Koshikawa N; Moriyama K; Takamura H; Mizushima H; Nagashima Y; Yanoma S; Miyazaki K
    Cancer Res; 1999 Nov; 59(21):5596-601. PubMed ID: 10554040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Precursors of endometrial clear cell carcinoma.
    Fadare O; Liang SX; Ulukus EC; Chambers SK; Zheng W
    Am J Surg Pathol; 2006 Dec; 30(12):1519-30. PubMed ID: 17122507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clear cell adenocarcinoma of the ovary arising in atypical endometriosis: a report of eight cases.
    Terada T
    Arch Gynecol Obstet; 2012 Jan; 285(1):229-33. PubMed ID: 21594603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laminin 5 beta3 and gamma2 chains are frequently coexpressed in cancer cells.
    Akimoto S; Nakanishi Y; Sakamoto M; Kanai Y; Hirohashi S
    Pathol Int; 2004 Sep; 54(9):688-92. PubMed ID: 15363037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small primary adenocarcinoma in adenomyosis with nodal metastasis: a case report.
    Puppa G; Shozu M; Perin T; Nomura K; Gloghini A; Campagnutta E; Canzonieri V
    BMC Cancer; 2007 Jun; 7():103. PubMed ID: 17584489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proliferative activity of early ovarian clear cell adenocarcinoma depends on association with endometriosis.
    Komiyama S; Aoki D; Katsuki Y; Nozawa S
    Eur J Obstet Gynecol Reprod Biol; 2006 Jul; 127(1):130-6. PubMed ID: 16442693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two kinds of endometrial neoplasia arising from different origins in the uterine corpus: comparison of p53 expression and sex steroid receptor status.
    Koshiyama M; Ueta M
    Eur J Obstet Gynecol Reprod Biol; 2002 Sep; 104(2):167-70. PubMed ID: 12206933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ovarian yolk sac tumor with endometrioid carcinoma arising from endometriosis in a postmenopausal woman, with special reference to expression of alpha-fetoprotein, sex steroid receptors, and p53.
    Horiuchi A; Osada R; Nakayama K; Toki T; Nikaido T; Fujii S
    Gynecol Oncol; 1998 Aug; 70(2):295-9. PubMed ID: 9740709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laminin-5 immunocytochemistry: a new tool for identifying dysplastic cells in oral brush biopsies.
    Driemel O; Dahse R; Hakim SG; Tsioutsias T; Pistner H; Reichert TE; Kosmehl H
    Cytopathology; 2007 Dec; 18(6):348-55. PubMed ID: 18031447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A role of thymidine phosphorylase and P53 tissue protein expression in biology of endometrial cancer.
    Mazurek A; Kuć P; Mazurek-Wadołkowska E; Laudański T
    Neoplasma; 2008; 55(3):261-5. PubMed ID: 18348659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laminin gamma2-chain fragment circulating level increases in patients with metastatic pancreatic ductal cell adenocarcinomas.
    Katayama M; Funakoshi A; Sumii T; Sanzen N; Sekiguchi K
    Cancer Lett; 2005 Jul; 225(1):167-76. PubMed ID: 15922869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Primary clear cell carcinoma arising in cystic adenomyosis of the uterus--a case report].
    Mori Y; Inoue Y; Sakai K; Koizumi M; Okamura N; Sato K; Mizuuchi H
    Nihon Sanka Fujinka Gakkai Zasshi; 1994 Sep; 46(9):915-7. PubMed ID: 7963893
    [No Abstract]   [Full Text] [Related]  

  • 20. Ovarian clear cell carcinoma with papillary features: a potential mimic of serous tumor of low malignant potential.
    Sangoi AR; Soslow RA; Teng NN; Longacre TA
    Am J Surg Pathol; 2008 Feb; 32(2):269-74. PubMed ID: 18223330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.